Clinical Trial Update: Soluble B7-H3 as a Biomarker for Osteosarcoma

View source ↗

Summary

This study investigates soluble B7-H3 as a biomarker for osteosarcoma progression. It is currently recruiting and sponsored by Peking University People's Hospit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Snippet

Sponsor: Peking University People's Hospital | Conditions: Biomarker, Progression | Status: RECRUITING